What is ProCure Proton Therapy Center?
ProCure Proton Therapy Center is a pioneering facility in New Jersey dedicated to advanced radiation cancer treatment. The center specializes in cutting-edge proton therapy, a highly precise method that targets tumors with exceptional accuracy, thereby minimizing damage to surrounding healthy tissues. This advanced treatment modality is effective for a range of cancers, including prostate, breast, and pediatric malignancies. ProCure is distinguished by its team of experienced radiation oncologists and support staff, committed to providing a supportive and welcoming environment for patients. The center actively collaborates with leading hospitals and oncology practices to broaden patient care options and treatment efficacy.
How much funding has ProCure Proton Therapy Center raised?
ProCure Proton Therapy Center has raised a total of $35M across 1 funding round:
Private Equity
$35M
Private Equity (2006): $35M with participation from McClendon venture
Key Investors in ProCure Proton Therapy Center
McClendon venture
McClendon venture is an investor participating in the funding round, likely focused on strategic growth opportunities within the healthcare sector.
What's next for ProCure Proton Therapy Center?
The recent major strategic investment signals a new phase of growth and development for ProCure Proton Therapy Center. This capital infusion is expected to fuel expansion initiatives, potentially including the enhancement of existing treatment technologies, the broadening of service offerings, or the establishment of new treatment centers. The company's focus on specialized proton therapy positions it for continued leadership in the oncology sector, attracting further investment and partnerships aimed at improving patient outcomes in the fight against cancer.
See full ProCure Proton Therapy Center company page
